Appointments

866.320.4573

Submit a Form

Questions

800.223.2273

Submit a Form

Expand Content

John Fung, MD, PhD

216.444.6665

John Fung, MD, PhD
Department: Digestive Disease Institute
Institute Chair
Location: Cleveland Clinic Main Campus
Mail Code A100
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6665
DeskDesk:216.444.5914
WorkFax:216.444.2153
John Fung, MD, PhD
Department: General Surgery Florida
Location: Florida, Weston
Mail Code A100
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:216.444.6665
DeskDesk:216.444.5914
WorkFax:216.444.2153
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

John J. Fung, MD, PhD, is the Chairman of the Digestive Disease Institute and the former Chairman of the Department of General Surgery at Cleveland Clinic.  Prior to this, he was the Chief of the Division of Transplant Surgery at the University of Pittsburgh. With more than 30 years involvement in kidney, liver, pancreas, islet, and intestinal transplantation, he is also an accomplished immunologist.

Dr. Fung received his BA from the Johns Hopkins University in 1975, and a PhD in Immunology in 1980 and MD in 1982 from the University of Chicago. He completed his surgical residency at the University of Rochester, and a transplant surgery fellowship at the University of Pittsburgh, under the guidance of Dr. Thomas Starzl.
 
Between 1987 and 1988, he served as Director of Histocompatibility Testing at the University of Rochester and is currently the Medical Director for Allogen Laboratory, the Histocompatibility Testing Laboratory used by the Cleveland Clinic. In 1989, he joined the faculty at the University of Pittsburgh, and he held the tenured position as the inaugural Thomas E. Starzl Professor in Surgery. He is currently Chairman of the Department of Surgery and Professor of Surgery at the Lerner College of Medicine at Case Western University.

Dr. Fung is a member of numerous scientific and surgical societies and served as President of the International Liver Transplantation Society from 1997-1999. He has published more than 1000 articles and book chapters and serves on the editorial board for several medical journals. He is the past Editor-in-Chief for Liver Transplantation, the highest impact factor specialty transplant journal.

His principal research interests are in transplantation immunology, immunosuppressive therapies, and liver related immunology. He has received funding from the NIH, the Juvenile Diabetes Foundation, as well as support from industry. In addition, he has received numerous prestigious lay and professional awards.

Dr. Fung is active in community affairs and has been a member of the Board of Directors at the Americans for Medical Progress, the LifeBanc Organ Procurement Organization and the American Liver Foundation. He received an honorable discharge from the United States Army Reserve Medical Corps with the rank of Lieutenant Colonel. He lives in Chagrin Falls, Ohio, with his wife, Beth, and four children, Justin, Lauren, Brendan and Shannon.

Professional Highlights

  • Past President, International Liver Transplantation Society
  • Past Editor-in-Chief, Liver Transplantation
  • Secretary & Treasurer, The Transplantation Society
  • Member, Secretary of Health and Human Services, Advisory Committee on Organ Transplantation
  • Inaugural Holder of the Thomas E. Starzl Professor of Surgery, University of Pittsburgh

Education & Fellowships

Fellowship - Strong Memorial Hospital of The University of Rochester
General Surgery
Rochester, NY USA
1988
Fellowship - University of Pittsburgh School of Medicine
Transplantation Surgery
Pittsburgh, PA USA
1986
Residency - Strong Memorial Hospital of The University of Rochester
General Surgery
Rochester, NY USA
1984
Internship - Strong Memorial Hospital of The University of Rochester
General Surgery
Rochester, NY USA
1983
Medical School - University of Chicago Pritzker School of Medicine
Chicago, IL USA
1982
Doctorate - University of Chicago
Immunology
Chicago, IL USA
1980
Undergraduate - Johns Hopkins University
Baltimore, MD USA
1975

Certifications

  • Surgery

Specialty Interests

liver, liver transplantation, living donor liver transplantation, Portal Hypertension, Liver Transplantation

Awards & Honors

  • American Liver Foundation Special Award for Leadership In Liver Transplantation, 1997
  • American Society of Transplantation/Novartis Clinical Science Award, 2002
  • Ronald W. Fish Humanitarian of the Year Award, 2003
  • Hopeman Lecture – Grove City College, 2004
  • John J. Fung Endowed Assistant Professorship in Transplant Surgery at the University of Pittsburgh, 2005
  • American Association for the Study of Liver Diseases Achievement in Liver Transplantation Award, 2006
  • University of Virginia – Rudolf Lecture in Surgery, 2006
  • University of Rochester – Seymour Schwartz Lecture in Surgery, 2007
  • American Society of Transplantation Surgery/Vanguard Committee Francis Moore Mentorship Award, 2008
  • International Liver Transplantation Society Lifetime Achievement Award in Liver Transplantation - 2009
  • The Transplantation Society - Roche Award for Worldwide Impact in Transplantation - 2010
  • Chosen by fellow physicians to be listed in "The Best Doctors in America" and "America’s Top Doctors," 1991-present (inclusive)

Innovations & Patents

  • New procedures to perform liver transplantation, e.g., use of the vascular stapler, devising the portocaval hemitransposition technique
  • Development of minimally invasive liver surgery techniques
  • Developing intestinal transplantation
  • Use of the radiofrequency ablation device for liver resections
  • Use of new preservation solutions for transplantation

Memberships

  • American Association Study of Liver Diseases
  • International Liver Transplantation Society
  • American Society of Transplant Surgeons
  • American Surgical Association
  • The Transplantation Society

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/30/2014, Dr. Fung has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Fung serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

  • Transplantation Society

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English